Method development and validation for determination of voglibose in tablet formulation using LC-MS/MS

4Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Voglibose is a potent a glucosidase inhibitor, used for the treatment of diabetes mellitus. For quantitative determination of voglibose in pharmaceutical formulations of low doses, simple, sensitive, accurate and precise LC-MS/MS method using electrospray ionization in positive mode was developed and validated. The method was found linear in the concentration range of 25.0-1200 hg/mL with a correlation coefficient of 0.9998. The limit of detection (LOD) of the method was found to be 1.5 hg/mL and limit of quantitation (LOQ) was achieved at 3.0 hg/mL. The recoveries of voglibose from spiked samples at different concentration levels were found in the range of 98-102%. The proposed method was found suitable for quantitation of voglibose and for the determination of uniformity of content of the dosage units of the tablet formulations. © Copyright E-Journal of Chemistry 2004-2011.

Cite

CITATION STYLE

APA

Rajput, M., Dahiya, M., Kumari, P., Kalra, K., Aggarwal, M., & Khandal, R. K. (2011). Method development and validation for determination of voglibose in tablet formulation using LC-MS/MS. E-Journal of Chemistry, 8(4), 1770–1783. https://doi.org/10.1155/2011/531762

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free